Chaim Lebovits insider trades
Open-market stock purchases and sales by Chaim Lebovits, President & CEO at Brainstorm Cell Therapeutics Inc, from SEC Form 4 filings since Sep 28, 2015.
Track record: 92% of 12 scored buys are up 5% or more since purchase, averaging +123%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 26, 2026 | BCLI Brainstorm Cell Therapeutics Inc | Bought (not open market) | — |
Companies traded
- BCLI Brainstorm Cell Therapeutics Inc: 13 buys, last Feb 26, 2026